| |
| |
|
| Insider
Information: |
Nazzi Gianfranco |
| Relationship: |
EVP, International Mar... |
| City: |
Petach Tikva |
| State: |
L3 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Teva Pharmaceutical Industries L... |
TEVA |
EVP, International Mar... |
2021-03-04 |
0 |
2018-03-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2021-03-04 |
4 |
AS |
$10.58 |
$136,909 |
D/D |
(12,935) |
0 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2021-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
12,935 |
12,935 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2021-03-03 |
4 |
AS |
$10.88 |
$15,231 |
D/D |
(1,400) |
0 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2021-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,400 |
1,400 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2021-03-01 |
4 |
AS |
$10.85 |
$821,925 |
D/D |
(75,587) |
0 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2021-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,177 |
75,587 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2021-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,941 |
31,785 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2021-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
50,260 |
82,045 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2021-02-09 |
4 |
AS |
$12.72 |
$275,217 |
D/D |
(21,635) |
60,410 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2020-03-17 |
4 |
AS |
$7.17 |
$2,474 |
D/D |
(345) |
19,844 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2020-03-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
874 |
20,189 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2020-03-03 |
4 |
AS |
$11.77 |
$6,448 |
D/D |
(548) |
19,315 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, International Markets |
• – – |
2020-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,399 |
19,863 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Growth Markets Commercial |
• – – |
2020-02-10 |
4 |
AS |
$12.24 |
$50,864 |
D/D |
(4,155) |
18,464 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Growth Markets Commercial |
• – – |
2020-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,941 |
22,619 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Growth Markets Commercial |
• – – |
2019-09-18 |
4 |
S |
$7.82 |
$7,523 |
D/D |
(962) |
10,678 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Growth Markets Commercial |
• – – |
2019-09-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,638 |
11,640 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Growth Markets Commercial |
• – – |
2019-03-18 |
4 |
S |
$16.64 |
$5,326 |
D/D |
(320) |
9,002 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Growth Markets Commercial |
• – – |
2019-03-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
872 |
9,322 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Growth Markets Commercial |
• – – |
2019-03-12 |
4 |
S |
$15.69 |
$5,099 |
D/D |
(325) |
8,450 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Growth Markets Commercial |
• – – |
2019-03-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
883 |
8,775 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Growth Markets Commercial |
• – – |
2019-03-04 |
4 |
S |
$16.88 |
$8,645 |
D/D |
(512) |
7,892 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Growth Markets Commercial |
• – – |
2019-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,399 |
8,404 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Growth Markets Commercial |
• – – |
2018-09-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,638 |
8,384 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Growth Markets Commercial |
• – – |
2018-09-18 |
4 |
S |
$23.69 |
$32,670 |
D/D |
(1,379) |
7,005 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
